Continuous processing is no longer a buzzword in pharma and biotech. Since we started the community in 2017, we have seen a surge of activities and progresses made in the industry globally. Through incremental steps, drug developers are moving through the journey of commercializing continuous manufacturing.
We’d like to thank you our speakers, event partners and participants who made the 3rd CCP Summit a huge success. It was a great testament to see how this community has expanded year-on-year, evidenced by the commercial activities in continuous manufacturing. In 2019 we saw the meeting grow to have parallel tracks catering for more robust and focussed discussions around small molecules and biologics respectively.
Our CCP community will return to Boston for the 4th time on Jan 28 – 30, 2020 – register your interest now and be the first to receive information from us.
"Great opportunity to exchange directly with the industry on case studies, suppliers and regulators. Very good organization!’’
"I really appreciate the professional organization! It was a good experience"
LEWA Bio Process Technologies